Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: LUPKYNIS Drug-use Results Survey

View source ↗

Summary

This ClinicalTrials.gov update describes a drug-use results survey for LUPKYNIS (voclosporin) in lupus nephritis, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUPKYNIS (voclosporin)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Lupus Nephritis | Status: RECRUITING